In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Akebia Therapeutics Inc. (NASDAQ: AKBA) closed at $1.37 in the last session, up 5.38% from day before closing price of $1.30. In other words, the price has increased by $5.38 from its previous closing price. On the day, 3.11 million shares were traded. AKBA stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.32.
Ratios:
We take a closer look at AKBA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.18.
On August 28, 2023, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.75.
Piper Sandler Upgraded its Neutral to Overweight on May 31, 2023, whereas the target price for the stock was revised from $2 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 29 ’24 when Butler John P. sold 46,570 shares for $1.58 per share. The transaction valued at 73,581 led to the insider holds 2,044,580 shares of the business.
Dahan Michel sold 8,661 shares of AKBA for $13,684 on Feb 29 ’24. The SVP, Chief Operating Officer now owns 706,932 shares after completing the transaction at $1.58 per share. On Feb 29 ’24, another insider, Burke Steven Keith, who serves as the SVP, Chief Medical Officer of the company, sold 7,169 shares for $1.58 each. As a result, the insider received 11,327 and left with 695,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKBA now has a Market Capitalization of 287145152 and an Enterprise Value of 348097024. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47. Its current Enterprise Value per Revenue stands at 1.789 whereas that against EBITDA is -50.684.
Stock Price History:
Over the past 52 weeks, AKBA has reached a high of $2.48, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is -12.17%, while the 200-Day Moving Average is calculated to be 3.33%.
Shares Statistics:
According to the various share statistics, AKBA traded on average about 4.92M shares per day over the past 3-months and 2586720 shares per day over the past 10 days. A total of 194.58M shares are outstanding, with a floating share count of 186.87M. Insiders hold about 10.84% of the company’s shares, while institutions hold 18.78% stake in the company. Shares short for AKBA as of 1713139200 were 13689136 with a Short Ratio of 2.78, compared to 1710460800 on 10126415. Therefore, it implies a Short% of Shares Outstanding of 13689136 and a Short% of Float of 6.6000000000000005.
